European Archives - Page 968 of 981 - European Medical Journal

EMJ

Western Doctor Dilemmas

Imagine making an appointment to see an electrician. You talk to them about the layout of your house and the fact that you want modern, artistic lighting…

EMJ

Khellin in Vitiligo Treatment

Psoralens + UVA (PUVA) therapy is a well-known treatment for vitiligo, as well as Narrowband-UVB (NB-UVB), but other photochemotherapy regimens for vitiligo

EMJ

Urology – Prostate Cancer Impacts

Prostate cancer does not stand alone as a disease affecting an individual. It has an impact on whole families and the circle of friends of each individual..

EMJ

A Personal Perspective on Testing for Prostate Cancer

As a urologist who has subspecialized in just the area of prostate disease, I see men with prostate cancer every working day.

EMJ

A very successful robotic urology meeting organised in Ankara, Turkey which transferred the experience of worldwide-known robotic surgeons from the USA and Canada to the participants

The 2nd Ankara Robotic Urology Symposium and Course was held between 7th-9th June 2013 at Yildirim Beyazit University, School of Medicine, Ankara…

EMJ

“See One, Do One… and Teach One”

Back in the old days, the traditional method of teaching in surgery was characterised by the American surgeon William Stewart Halsted‘s three phrases:…

EMJ

Cracking the Cancer-Code

The world of medicine and science changed forever the day scientists Watson and Crick discovered the structure of the double helix of DNA, which underpins..

EMJ

Contact Lenses and Acanthamoeba Keratitis

Contact lenses are medical devices and not a makeup tool. According to my 35 years’ experience in Egypt, if the population understands this phrase…

EMJ

Welcome to the new and improved EMJ – Blog!

Now we are all settled into the New Year, we would like to take the opportunity to fill you in with what’s new here at EMJ and what’s install for the rest..

EMJ

IMBRUVICA™ (Ibrutinib) Now Approved in the u.s. For Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy

HORSHAM, PA, February 12, 2014 – Janssen Biotech, Inc. [“Janssen”] today announced the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™…